How effective is Lorazepam for Generalized Anxiety Disorder? (a real world drug study)
Summary:
Overall ratings: 3.4/5 Long term ratings: 3.6/5
This is a phase IV clinical study of how effective Lorazepam (lorazepam) is for Generalized anxiety disorder and for what kind of people. The study is created by eHealthMe from 324 Lorazepam users and is updated continuously.
What is Lorazepam?
Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.
What is Generalized anxiety disorder?
Generalized anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry) is found to be associated with 769 drugs and 1,534 conditions by eHealthMe. Check the latest studies of Generalized anxiety disorder.
324 people are studied for taking Lorazepam in Generalized anxiety disorder
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Lorazepam effectiveness for Generalized anxiety disorder (number of people):
Overall:
- not at all: 5
- somewhat: 58
- moderate: 119
- high: 94
- very high: 48
Long Term:
- not at all: 1
- somewhat: 20
- moderate: 69
- high: 66
- very high: 29
Gender of people who take Lorazepam for Generalized anxiety disorder *:
- female: 71.91 %
- male: 28.09 %
Age of people who take Lorazepam for Generalized anxiety disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 2.16 %
- 20-29: 18.52 %
- 30-39: 22.53 %
- 40-49: 22.53 %
- 50-59: 18.52 %
- 60+: 15.74 %
Who find Lorazepam more effective for Generalized Anxiety Disorder?
Gender of people who take Lorazepam for Generalized anxiety disorder *:
- female: 69.72 %
- male: 30.28 %
Age of people who take Lorazepam for Generalized anxiety disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 2.11 %
- 20-29: 15.49 %
- 30-39: 17.61 %
- 40-49: 28.87 %
- 50-59: 21.13 %
- 60+: 14.79 %
* Approximation only. Some reports may have incomplete information.
Do you take Lorazepam?
- You can start a phase IV clinical trial to monitor Lorazepam safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Ahmed AB, Radwan AM, Baddary HM, "Prevalence of Generalized Anxiety Disorder in Patients with Rheumatoid Arthritis and its Relationship with Disease Activity", The Egyptian Journal of Hospital Medicine, 2016 Jan .
- Ahmed AB, Radwan AM, Baddary HM, "Prevalence of Generalized Anxiety Disorder in Patients with Rheumatoid Arthritis and its Relationship with Disease Activity", The Egyptian Journal of Hospital Medicine, 2016 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Lorazepam (165,639 reports)
Treatments, associated drugs and conditions:
- Generalized anxiety disorder (31,279 reports)
How the study uses the data?
The study is based on lorazepam (the active ingredients of Lorazepam) and Lorazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Effexor and Jantoven - 9 seconds ago
- Could Mycophenolate Mofetil cause Gastrointestinal Tract Adenoma? - 9 seconds ago
- Could Ramipril cause Tongue Dry? - 26 seconds ago
- Drug interactions of Tasigna and Neoral - 27 seconds ago
- Could Mycobutin cause Deafness Traumatic? - 36 seconds ago
- Drug interactions of Alprazolam and Wixela Inhub - 37 seconds ago
- Drug interactions of Dolutegravir and Mycophenolic Acid - 38 seconds ago
- Drug interactions of Estrace and Pregabalin - 39 seconds ago
- Could Dulera cause Bronchospasm Aggravated? - 50 seconds ago
- Could Vitamin E cause Tumor? - a minute ago